vs

Side-by-side financial comparison of Edwards Lifesciences (EW) and North American Construction Group Ltd. (NOA). Click either name above to swap in a different company.

Edwards Lifesciences is the larger business by last-quarter revenue ($1.6B vs $860.2M, roughly 1.9× North American Construction Group Ltd.). Edwards Lifesciences runs the higher net margin — 23.1% vs 4.7%, a 18.4% gap on every dollar of revenue. Over the past eight quarters, North American Construction Group Ltd.'s revenue compounded faster (58.0% CAGR vs 9.7%).

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter.

Shanghai Construction (Group) Corporation (SCG) is a Chinese construction and engineering company, ranked as the 16th largest construction company in the world based on 2011 revenues.

EW vs NOA — Head-to-Head

Bigger by revenue
EW
EW
1.9× larger
EW
$1.6B
$860.2M
NOA
Higher net margin
EW
EW
18.4% more per $
EW
23.1%
4.7%
NOA
Faster 2-yr revenue CAGR
NOA
NOA
Annualised
NOA
58.0%
9.7%
EW

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
EW
EW
NOA
NOA
Revenue
$1.6B
$860.2M
Net Profit
$380.7M
$40.5M
Gross Margin
78.0%
19.7%
Operating Margin
1.8%
15.4%
Net Margin
23.1%
4.7%
Revenue YoY
16.7%
Net Profit YoY
6.8%
EPS (diluted)
$0.66

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EW
EW
NOA
NOA
Q1 26
$1.6B
Q4 25
$1.6B
Q3 25
$1.6B
$860.2M
Q2 25
$1.5B
$573.3M
Q1 25
$1.4B
$297.0M
Q4 24
$1.4B
Q3 24
$1.4B
$636.4M
Q2 24
$1.4B
$439.5M
Net Profit
EW
EW
NOA
NOA
Q1 26
$380.7M
Q4 25
$91.2M
Q3 25
$291.1M
$40.5M
Q2 25
$333.2M
$26.0M
Q1 25
$358.0M
$11.5M
Q4 24
$385.6M
Q3 24
$3.1B
$45.5M
Q2 24
$366.3M
$34.1M
Gross Margin
EW
EW
NOA
NOA
Q1 26
78.0%
Q4 25
78.1%
Q3 25
77.8%
19.7%
Q2 25
77.5%
18.1%
Q1 25
78.7%
18.0%
Q4 24
78.9%
Q3 24
80.6%
14.0%
Q2 24
79.9%
14.3%
Operating Margin
EW
EW
NOA
NOA
Q1 26
1.8%
Q4 25
9.6%
Q3 25
19.8%
15.4%
Q2 25
26.8%
13.6%
Q1 25
27.9%
13.0%
Q4 24
22.6%
Q3 24
25.9%
7.9%
Q2 24
26.8%
8.2%
Net Margin
EW
EW
NOA
NOA
Q1 26
23.1%
Q4 25
5.8%
Q3 25
18.7%
4.7%
Q2 25
21.7%
4.5%
Q1 25
25.3%
3.9%
Q4 24
27.8%
Q3 24
226.7%
7.1%
Q2 24
26.7%
7.8%
EPS (diluted)
EW
EW
NOA
NOA
Q1 26
$0.66
Q4 25
$0.16
Q3 25
$0.50
Q2 25
$0.56
Q1 25
$0.61
Q4 24
$0.65
Q3 24
$5.13
Q2 24
$0.61

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EW
EW
NOA
NOA
Operating Cash FlowLast quarter
$140.7M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.47×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EW
EW
NOA
NOA
Q1 26
Q4 25
$450.9M
Q3 25
$573.7M
$140.7M
Q2 25
$290.2M
$85.4M
Q1 25
$280.4M
$19.0M
Q4 24
$-127.5M
Q3 24
$351.8M
$109.5M
Q2 24
$371.5M
$72.0M
Free Cash Flow
EW
EW
NOA
NOA
Q1 26
Q4 25
$353.5M
Q3 25
$516.2M
Q2 25
$240.9M
Q1 25
$224.4M
Q4 24
$-177.3M
Q3 24
$299.9M
Q2 24
$286.1M
FCF Margin
EW
EW
NOA
NOA
Q1 26
Q4 25
22.5%
Q3 25
33.2%
Q2 25
15.7%
Q1 25
15.9%
Q4 24
-12.8%
Q3 24
22.1%
Q2 24
20.9%
Capex Intensity
EW
EW
NOA
NOA
Q1 26
Q4 25
6.2%
Q3 25
3.7%
Q2 25
3.2%
Q1 25
4.0%
Q4 24
3.6%
Q3 24
3.8%
Q2 24
6.2%
Cash Conversion
EW
EW
NOA
NOA
Q1 26
Q4 25
4.94×
Q3 25
1.97×
3.47×
Q2 25
0.87×
3.28×
Q1 25
0.78×
1.65×
Q4 24
-0.33×
Q3 24
0.11×
2.41×
Q2 24
1.01×
2.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons